Literature DB >> 8895585

Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.

S R Shih1, R M Krug.   

Abstract

We show that a cellular nuclear protein, the SR splicing factor SF2/ASF, controls the level of production of an essential influenza virus protein, the M2 ion channel protein. The M2 mRNA that encodes the ion channel protein is produced by alternative splicing of another viral mRNA, M1 mRNA. The production of M2 mRNA is controlled in two ways. First, a distal (stronger) 5' splice site in M1 mRNA is blocked by the complex of viral polymerase proteins synthesized during infection, allowing the cellular splicing machinery to switch to the proximal (weaker) M2 5' splice site. Second, utilization of the weak M2 5' splice site requires its activation by the cellular SF2/ASF protein. This activation is mediated by the binding of the SF2/ASF protein to a purine-rich splicing enhancer sequence that is located in the 3' exon of M1 mRNA. We demonstrate that activation of the M2 5' splice site is controlled by the SF2/ASF protein in vivo during influenza virus infection. Utilizing four cell lines that differ in their levels of production of the SF2/ASF protein, we show that during virus infection of these cell lines both M2 mRNA and the M2 ion channel protein are produced in amounts that are proportional to the different expression levels of the SF2/ASF protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895585      PMCID: PMC452284     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Sex-specific alternative splicing of RNA from the transformer gene results from sequence-dependent splice site blockage.

Authors:  B A Sosnowski; J M Belote; M McKeown
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

2.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

3.  The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.

Authors:  M Hadzopoulou-Cladaras; B K Felber; C Cladaras; A Athanassopoulos; A Tse; G N Pavlakis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

5.  Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

Authors:  M H Malim; S Böhnlein; J Hauber; B R Cullen
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

6.  Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1).

Authors:  R A Lamb; C J Lai
Journal:  Virology       Date:  1982-12       Impact factor: 3.616

7.  Differences in the control of virus mRNA splicing during permissive or abortive infection with influenza A (fowl plague) virus.

Authors:  S C Inglis; C M Brown
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

8.  Binding of the Drosophila sex-lethal gene product to the alternative splice site of transformer primary transcript.

Authors:  K Inoue; K Hoshijima; H Sakamoto; Y Shimura
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

9.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.

Authors:  R Tacke; J L Manley
Journal:  EMBO J       Date:  1995-07-17       Impact factor: 11.598

View more
  32 in total

1.  Identification of two human nuclear proteins that recognise the cytosine-rich strand of human telomeres in vitro.

Authors:  L Lacroix; H Liénard; E Labourier; M Djavaheri-Mergny; J Lacoste; H Leffers; J Tazi; C Hélène; J L Mergny
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

Review 2.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Overexpression of essential splicing factor ASF/SF2 blocks the temporal shift in adenovirus pre-mRNA splicing and reduces virus progeny formation.

Authors:  M Molin; G Akusjärvi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus.

Authors:  L M McNally; M T McNally
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

5.  Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate.

Authors:  Chiayn Chiang; Guang-Wu Chen; Shin-Ru Shih
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

6.  Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth.

Authors:  Chao Li; Lv-Jie Xu; Wen-Wen Lian; Xiao-Cong Pang; Hao Jia; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharmacol Sin       Date:  2018-05-25       Impact factor: 6.150

7.  Influenza C virus NS1 protein upregulates the splicing of viral mRNAs.

Authors:  Yasushi Muraki; Takatoshi Furukawa; Yoshihiko Kohno; Yoko Matsuzaki; Emi Takashita; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Authors:  Alexander Karlas; Nikolaus Machuy; Yujin Shin; Klaus-Peter Pleissner; Anita Artarini; Dagmar Heuer; Daniel Becker; Hany Khalil; Lesley A Ogilvie; Simone Hess; André P Mäurer; Elke Müller; Thorsten Wolff; Thomas Rudel; Thomas F Meyer
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

9.  A novel spliced transcript of influenza A/WSN/33 virus.

Authors:  S R Shih; P C Suen; Y S Chen; S C Chang
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

10.  The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture.

Authors:  David Jackson; Robert A Lamb
Journal:  J Gen Virol       Date:  2008-12       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.